WX is excited to announce our recent successful play on $MYOV!
We recommended this stock in early October after the market overreacted to lackluster data in prostate cancer. Our subscribers were able to get in at around $15 a share!
Since then, there has been a significant upward price movement given recent regulatory events. We are proud that our subscribers were able to take profits of 60 - 80%!
Does $MYOV still have room to grow? Want to get up to date biotech stock picks? Consider subscribing today!